World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33070930

Number of visits today: 4152

Number of downloads: 16272532

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Sinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Phase 3, multicentre, double-blind, randomised, parallel-group, placebo-controlled study of camostat mesilate (FOY-305) for the treatment of COVID-19 (CANDLE study).. [DOI: 10.1101/2022.03.27.22271988] [Cited by in F6Publishing: 1] [Reference Citation Analysis]

For:

Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Sinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Phase 3, multicentre, double-blind, randomised, parallel-group, placebo-controlled study of camostat mesilate (FOY-305) for the treatment of COVID-19 (CANDLE study).. [DOI: 10.1101/2022.03.27.22271988] [Cited by in F6Publishing: 1] [Reference Citation Analysis]

Number	Citing Articles
1	Li J, Xue Y, Wang X, Smith LS, He B, Liu S, Zhu HJ. Tissue- and cell-expression of druggable host proteins provide insights into repurposing drugs for COVID-19. Clin Transl Sci 2022;15:2796-811. [PMID: 36259251 DOI: 10.1111/cts.13400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]